Laurus Labs PAT at Rs 201.90 cr. in Q2FY21

Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021

Merck expands capacity for Antibody Drug Conjugate (ADC), therapies

Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges

Takeda to acquire GammaDelta Therapeutics

The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies

3M Health Care and Thermo Fisher to increase efficiency in therapeutic manufacturing

Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers

Boehringer Ingelheim announces EMA marketing authorisation for spesolimab

Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules

Transforming Healthcare Through AI

Yashoda Hospitals opens world-class Biplane Neuro Cath lab for brain stroke

It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology

AstraZeneca partners with India-Sweden Healthcare Innovation Centre and AIIMS to upskill nurses

This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one

Indian Pharma Market witnesses rise in volumes and prices in September.

Acute therapies continue to report strong growth compared to chronic ones.

MSD and MPP sign licensing agreement to make molnupiravir affordable

In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.